Strongest sign yet of UK asbestos R&D centre go-ahead
This article was originally published in Clinica
Executive Summary
The UK government is reportedly ready to give the go-ahead to the national R&D centre for asbestos-related diseases (NCARD), as part of a wider package of care and exposure compensation measures.